Cite
HARVARD Citation
Prasinou, M. et al. (n.d.). 335. ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHÇET'S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL OF EFFICACY AND SAFETY (ALEVIATE). Rheumatology. p. . [Online].